Vacuna de Merck-Moderna reduce riesgo de reaparición del cáncer de piel

Merck-Moderna Vaccine Cuts Risk of Skin Cancer Returning


“Today is a huge day of hope for cancer patients,” says Moderna CEO Stephane Bancel as he discusses data on a personalized vaccine developed by Merck & Co. and Moderna Inc. that helped prevent the recurrence of severe skin cancer for three years

Fuente: Youtube